Outcome in disappearing colorectal cancer liver metastases during oxaliplatin-based chemotherapy

Ono,Tomojiro; Ishida,Hideyuki; Kumamoto,Kensuke; Okada,Norimichi; Ishibashi,Keiichiro

doi:10.3892/ol.2012.842

November 2012 Volume 4 Issue 5

Full Size Image

Journals

International Journal of Molecular Medicine

International Journal of Molecular Medicine is an international journal devoted to molecular mechanisms of human disease.

International Journal of Oncology

International Journal of Oncology is an international journal devoted to oncology research and cancer treatment.

Molecular Medicine Reports

Covers molecular medicine topics such as pharmacology, pathology, genetics, neuroscience, infectious diseases, molecular cardiology, and molecular surgery.

Oncology Reports

Oncology Reports is an international journal devoted to fundamental and applied research in Oncology.

Experimental and Therapeutic Medicine

Experimental and Therapeutic Medicine is an international journal devoted to laboratory and clinical medicine.

Oncology Letters

Oncology Letters is an international journal devoted to Experimental and Clinical Oncology.

Biomedical Reports

Explores a wide range of biological and medical fields, including pharmacology, genetics, microbiology, neuroscience, and molecular cardiology.

Molecular and Clinical Oncology

International journal addressing all aspects of oncology research, from tumorigenesis and oncogenes to chemotherapy and metastasis.

World Academy of Sciences Journal

Multidisciplinary open-access journal spanning biochemistry, genetics, neuroscience, environmental health, and synthetic biology.

International Journal of Functional Nutrition

Open-access journal combining biochemistry, pharmacology, immunology, and genetics to advance health through functional nutrition.

International Journal of Epigenetics

Publishes open-access research on using epigenetics to advance understanding and treatment of human disease.

Medicine International

An International Open Access Journal Devoted to General Medicine.

November 2012 Volume 4 Issue 5

Full Size Image

Article

Outcome in disappearing colorectal cancer liver metastases during oxaliplatin-based chemotherapy

Authors:
- Tomojiro Ono
- Hideyuki Ishida
- Kensuke Kumamoto
- Norimichi Okada
- Keiichiro Ishibashi
View Affiliations / Copyright

Affiliations: Department of Digestive Tract and General Surgery, Saitama Medical Center, Saitama Medical University, Kawagoe, Saitama 350-8550, Japan
Pages: 905-909
|
Published online on: August 3, 2012

https://doi.org/10.3892/ol.2012.842
Expand metrics +

Abstract

Some colorectal cancer liver metastases (CLMs) disappear on serial imaging during chemotherapy and the optimal treatment strategy for such lesions remains undetermined. The purpose of this study was to investigate the outcome in disappearing CLMs, as few studies have focused on this topic, with conflicting results. Among 125 patients with CLMs treated with modified FOLFOX6 with or without bevacizumab, those in whom all CLMs disappeared on computed tomography were identified. Recurrence of such disappearing lesions in situ was examined on a tumor-by‑tumor basis. Five (4%) patients with a total of 44 CLMs met the evaluation criteria. The median number of CLMs prior to chemotherapy was 8 (range, 2-16). The median maximal diameter of the CLMs was 1.8 cm (range, 1.0-2.4). The median time-to-disappearance of all eligible lesions was 6.5 months (range, 4.5-7.5). Histological examination of scar lesions on the liver surface revealed no viable cancer cells. Two lesions were surgically resected. During clinical follow-up of the remaining 42 lesions, in situ recurrence was observed in 8. The cumulative 1-, 2- and 3-year rates of relapse in situ were 9.1, 9.1 and 31.1%, respectively. Given the low risk of recurrence in situ, the results suggest that the sites of disappearing CLMs may be left unresected but should be carefully monitored during follow-up, with resection an option if the lesion should recur. However, to validate such a treatment strategy, further investigation with a larger series of patients is warranted.

View Figures

View References

1.	B NordlingerH SorbyeB GlimeliusEORTC Gastro-Intestinal Tract Cancer Group; Cancer Research UK; Arbeitsgruppe Lebermetastasen und-tumoren in der Chirurgischen Arbeitsgemeinschaft Onkologie (ALM-CAO); Australasian Gastro-Intestinal Trials Group (AGITG); Fédération Francophone de Cancérologie Digestive (FFCD)Perioperative chemotherapy with FOLFOX4 and surgery versus surgery alone for resectable liver metastases from colorectal cancer (EORTC Intergroup trial 40983): a randomised controlled trialLancet37110071016200810.1016/S0140-6736(08)60455-9
2.	R WongD CunninghamY BarbachanoA multicentre study of capecitabine, oxaliplatin plus bevacizumab as perioperative treatment of patients with poor-risk colorectal liver-only metastases not selected for upfront resectionAnn Oncol2220422048201110.1093/annonc/mdq71421285134
3.	C BokemeyerI BondarenkoA MakhsonFluorouracil, leucovorin, and oxaliplatin with and without cetuximab in the first-line treatment of metastatic colorectal cancerJ Clin Oncol27663671200010.1200/JCO.2008.20.839719114683
4.	National Cancer InstituteCommon terminology criteria for adverse events (CTCAE) v4.0http://ctep.cancer.gov/protocolDevelopment/electronic_applications/ctc.htm#ctc_40. Accessed April 23, 2012.
5.	S BenoistA BrouquetC PennaComplete response of colorectal liver metastases after chemotherapy: does it mean cure?J Clin Oncol2439393945200610.1200/JCO.2006.05.872716921046
6.	G FiorentiniA Del ConteM De SimoneComplete response of colorectal liver metastases after intra-arterial chemotherapyTumori94489492200818822683
7.	D EliasD GoereV BoigeN Kohneh-SharhiD MalkaG TomasicC DromainM DucreuxOutcome of posthepatectomy-missing colorectal liver metastases after complete response to chemotherapy: impact of adjuvant intra-arterial hepatic oxaliplatinAnn Surg Oncol1431883194200710.1245/s10434-007-9482-9
8.	RC AuerRR WhiteNE KemenyPredictors of a true complete response among disappearing liver metastases from colorectal cancer after chemotherapyCancer11615021509201010.1002/cncr.2491220120032
9.	MG van VledderMC de JongTM PawlikRD SchulickLA DiazMA ChotiDisappearing colorectal liver metastases after chemotherapy: should we be concerned?J Gastrointest Surg1416911700201020839072
10.	K TanakaH TakakuraK TakedaK MatuoY NaganoI EndoImportance of complete pathologic response to prehepatectomy chemotherapy in treating colorectal cancer metastasesAnn Surg250935942200910.1097/SLA.0b013e3181b0c6e419953712
11.	M KlingerS EpieldauerS HackerBevacizumab protects against sinusoidal obstruction syndrome and does not increase response rate in neoadjuvant XELOX/FOLFOX therapy of colorectal cancer liver metastasesEur J Surg Oncol35515520200910.1016/j.ejso.2008.12.013
12.	EA EisenhauerP TherasseJ BogaertsNew response evaluation criteria in solid tumors: revised RECIST guideline (version 1.1)Eur J Cancer45228247200910.1016/j.ejca.2008.10.026
13.	S BhattacharjyaT BhattacharjyaS BaberJM TibballsAF WatkinsonBR DavidsonProspective study of contrast-enhanced computed tomography, computed tomography during arterioportography, and magnetic resonance imaging for staging colorectal liver metastases for liver resectionBr J Surg9113611369200410.1002/bjs.4699
14.	S BipatMS van LeeuwenEF ComansColorectal liver metastases: CT, MR imaging, and PET for diagnosis - meta-analysisRadiology237123131200510.1148/radiol.237104206016100087
15.	C VallasE AndíaA SánchezHepatic metastases from colorectal cancer: Preoperative detection and assessment of respectability with helical CTRadiology2185560200110.1148/radiology.218.1.r01dc115511152779
16.	D EliasL SiderisM PocardIncidence of unsuspected and treatable metastatic disease associated with operable colorectal liver metastases discovered only at laparotomy (and not treated when performing percutaneous radiofrequency ablation)Ann Surg Oncol12298302200510.1245/ASO.2005.03.020
17.	FG FernandezJ RitterJW GoodwinDC LinehanWG HawkinsSM StrasbergEffect of steatohepatitis associated with irinotecan or oxaliplatin pretreatment on resectability of hepatic colorectal metastasesJ Am Coll Surg200845853200510.1016/j.jamcollsurg.2005.01.024

Journals

International Journal of Molecular Medicine

International Journal of Oncology

Molecular Medicine Reports

Oncology Reports

Experimental and Therapeutic Medicine

Oncology Letters

Biomedical Reports

Molecular and Clinical Oncology

World Academy of Sciences Journal

International Journal of Functional Nutrition

International Journal of Epigenetics

Medicine International

Outcome in disappearing colorectal cancer liver metastases during oxaliplatin-based chemotherapy

This article is mentioned in:

Abstract

Figure 1

Figure 2

Figure 3

Related Articles